[Nicotinic acetylcholine receptor in Alzheimer's disease].

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Nicotinic acetylcholine receptor (nAChR) mediates pleiotropic actions in brain not only for nicotinic neurotransmission but also glutamatergic, dopaminergic, norepinephrinergic, GABAergic, and serotonergic transmissions, especially through allosteric potentiating ligand (APL) action. Because nAChR is rich in thalamus, the direct stimulation of nAChR through APL action is expected to show increasing function of cerebral cortex and limbic system through thalamic activation. In fact, a choline esterase inhibitor with this APL action such as galantamine exerts both cognitive and affective improvements which is called dual benefit for Alzheimer's disease patients.

Original languageEnglish
Pages (from-to)743-750
Number of pages8
JournalNihon rinsho. Japanese journal of clinical medicine
Volume71
Issue number4
Publication statusPublished - Apr 2013

Fingerprint

Nicotinic Receptors
Alzheimer Disease
Ligands
Galantamine
Limbic System
Esterases
Choline
Thalamus
Synaptic Transmission
Cerebral Cortex
Brain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Nicotinic acetylcholine receptor in Alzheimer's disease]. / Abe, Koji.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 71, No. 4, 04.2013, p. 743-750.

Research output: Contribution to journalArticle

@article{82236445aed14941946a778576aa0aaa,
title = "[Nicotinic acetylcholine receptor in Alzheimer's disease].",
abstract = "Nicotinic acetylcholine receptor (nAChR) mediates pleiotropic actions in brain not only for nicotinic neurotransmission but also glutamatergic, dopaminergic, norepinephrinergic, GABAergic, and serotonergic transmissions, especially through allosteric potentiating ligand (APL) action. Because nAChR is rich in thalamus, the direct stimulation of nAChR through APL action is expected to show increasing function of cerebral cortex and limbic system through thalamic activation. In fact, a choline esterase inhibitor with this APL action such as galantamine exerts both cognitive and affective improvements which is called dual benefit for Alzheimer's disease patients.",
author = "Koji Abe",
year = "2013",
month = "4",
language = "English",
volume = "71",
pages = "743--750",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "4",

}

TY - JOUR

T1 - [Nicotinic acetylcholine receptor in Alzheimer's disease].

AU - Abe, Koji

PY - 2013/4

Y1 - 2013/4

N2 - Nicotinic acetylcholine receptor (nAChR) mediates pleiotropic actions in brain not only for nicotinic neurotransmission but also glutamatergic, dopaminergic, norepinephrinergic, GABAergic, and serotonergic transmissions, especially through allosteric potentiating ligand (APL) action. Because nAChR is rich in thalamus, the direct stimulation of nAChR through APL action is expected to show increasing function of cerebral cortex and limbic system through thalamic activation. In fact, a choline esterase inhibitor with this APL action such as galantamine exerts both cognitive and affective improvements which is called dual benefit for Alzheimer's disease patients.

AB - Nicotinic acetylcholine receptor (nAChR) mediates pleiotropic actions in brain not only for nicotinic neurotransmission but also glutamatergic, dopaminergic, norepinephrinergic, GABAergic, and serotonergic transmissions, especially through allosteric potentiating ligand (APL) action. Because nAChR is rich in thalamus, the direct stimulation of nAChR through APL action is expected to show increasing function of cerebral cortex and limbic system through thalamic activation. In fact, a choline esterase inhibitor with this APL action such as galantamine exerts both cognitive and affective improvements which is called dual benefit for Alzheimer's disease patients.

UR - http://www.scopus.com/inward/record.url?scp=84891718547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891718547&partnerID=8YFLogxK

M3 - Article

C2 - 23678610

AN - SCOPUS:84891718547

VL - 71

SP - 743

EP - 750

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 4

ER -